Gene Therapy Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Gene Therapy market was valued at 859 Million US$ in 2018 and is projected to reach 6826 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 29.57% during the forecast period.
This report presents the market size and development trends by detailing the Gene Therapy market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Gene Therapy market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Gene Therapy industry and will help you to build a panoramic view of the industrial development.
Gene Therapy Market, By Type:
Viral vector
Non-viral vector
Gene Therapy Market, By Application:
Oncological Disorders
Rare Diseases
Cardiovascular Diseases
Neurological Disorders
Infectious disease
Other Diseases
Some of the leading players are as follows:
Sibiono GeneTech
Advantagene
UniQure NV
Celladon
Shanghai Sunway Biotech Co. Ltd
Spark Therapeutics
Sangamo
Bluebird Bio
Avalanche Bio
Dimension Therapeutics
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Gene Therapy Market: Technology Type Analysis
-
4.1 Gene Therapy Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Gene Therapy Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Viral vector
4.3.2 Non-viral vector
5 Gene Therapy Market: Product Analysis
-
5.1 Gene Therapy Product Market Share Analysis, 2018 & 2026
-
5.2 Gene Therapy Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Gene Therapy Market: Application Analysis
-
6.1 Gene Therapy Application Market Share Analysis, 2018 & 2026
-
6.2 Gene Therapy Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Oncological Disorders
6.3.2 Rare Diseases
6.3.3 Cardiovascular Diseases
6.3.4 Neurological Disorders
6.3.5 Infectious disease
6.3.6 Other Diseases
7 Gene Therapy Market: Regional Analysis
-
7.1 Gene Therapy Regional Market Share Analysis, 2018 & 2026
-
7.2 Gene Therapy Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sibiono GeneTech
9.1.1 Sibiono GeneTech Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Advantagene
9.2.1 Advantagene Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 UniQure NV
9.3.1 UniQure NV Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Celladon
9.4.1 Celladon Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Shanghai Sunway Biotech Co. Ltd
9.5.1 Shanghai Sunway Biotech Co. Ltd Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Spark Therapeutics
9.6.1 Spark Therapeutics Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Sangamo
9.7.1 Sangamo Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Bluebird Bio
9.8.1 Bluebird Bio Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Avalanche Bio
9.9.1 Avalanche Bio Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Dimension Therapeutics
9.10.1 Dimension Therapeutics Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
The List of Tables and Figures (Totals 111 Figures and 127 Tables)
Figure Viral vector Gene Therapy market, 2015 - 2026 (USD Million)
Figure Non-viral vector Gene Therapy market, 2015 - 2026 (USD Million)
Figure Oncological Disorders market, 2015 - 2026 (USD Million)
Figure Rare Diseases market, 2015 - 2026 (USD Million)
Figure Cardiovascular Diseases market, 2015 - 2026 (USD Million)
Figure Neurological Disorders market, 2015 - 2026 (USD Million)
Figure Infectious disease market, 2015 - 2026 (USD Million)
Figure Other Diseases market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Gene Therapy market, by country, 2015 - 2026 (USD Million)
-
Table North America Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table North America Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table North America Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Canada Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Canada Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Europe Gene Therapy market, by country, 2015 - 2026 (USD Million)
-
Table Europe Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Europe Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Europe Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Germany Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Germany Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table France Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table France Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Italy Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Italy Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Spain Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Spain Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gene Therapy market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table China Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table China Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Japan Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Japan Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table India Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table India Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Gene Therapy market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table MEA Gene Therapy market, by country, 2015 - 2026 (USD Million)
-
Table MEA Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table MEA Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table MEA Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Gene Therapy market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Gene Therapy market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Gene Therapy market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sibiono GeneTech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Advantagene Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table UniQure NV Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celladon Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai Sunway Biotech Co. Ltd Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Spark Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sangamo Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bluebird Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Avalanche Bio Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Dimension Therapeutics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Report Purchase
